- Home
- SYRE vs GAM Comparison
SYRE vs GAM Comparison
Compare SYRE & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- GAM
- Stock Information
- Founded
- SYRE 2013
- GAM 1927
- Country
- SYRE United States
- GAM United States
- Employees
- SYRE 60
- GAM N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- GAM Investment Managers
- Sector
- SYRE Health Care
- GAM Finance
- Exchange
- SYRE Nasdaq
- GAM Nasdaq
- Market Cap
- SYRE 1.3B
- GAM 1.2B
- IPO Year
- SYRE 2016
- GAM N/A
- Fundamental
- Price
- SYRE $21.29
- GAM $52.04
- Analyst Decision
- SYRE Strong Buy
- GAM
- Analyst Count
- SYRE 8
- GAM 0
- Target Price
- SYRE $51.50
- GAM N/A
- AVG Volume (30 Days)
- SYRE 550.7K
- GAM 20.1K
- Earning Date
- SYRE 03-03-2025
- GAM 01-01-0001
- Dividend Yield
- SYRE N/A
- GAM 5.74%
- EPS Growth
- SYRE N/A
- GAM N/A
- EPS
- SYRE N/A
- GAM 11.67
- Revenue
- SYRE N/A
- GAM N/A
- Revenue This Year
- SYRE $168.62
- GAM N/A
- Revenue Next Year
- SYRE $47.61
- GAM N/A
- P/E Ratio
- SYRE N/A
- GAM $3.95
- Revenue Growth
- SYRE N/A
- GAM N/A
- 52 Week Low
- SYRE $20.13
- GAM $37.32
- 52 Week High
- SYRE $47.97
- GAM $46.48
- Technical
- Relative Strength Index (RSI)
- SYRE 40.66
- GAM 44.20
- Support Level
- SYRE $21.61
- GAM $52.20
- Resistance Level
- SYRE $23.04
- GAM $52.96
- Average True Range (ATR)
- SYRE 1.43
- GAM 0.49
- MACD
- SYRE -0.03
- GAM -0.08
- Stochastic Oscillator
- SYRE 22.03
- GAM 12.75
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.